← Back to Search

Optical Coherence Tomography System

Optical imaging of the cornea in healthy subjects for Corneas

N/A
Waitlist Available
Led By Seok-Hyun Yun, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test a new eye-scanning technology to see if it can provide information about the cornea's mechanics.

Eligible Conditions
  • Corneas

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of subjects to successfully complete OCT Vibrography without serious unanticipated adverse events related to application of the device.
Secondary outcome measures
Microscopy

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy subjectsExperimental Treatment1 Intervention
Optical imaging of the cornea in healthy subjects
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Optical imaging of the cornea in healthy subjects
2019
N/A
~50

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,309 Total Patients Enrolled
1 Trials studying Corneas
90 Patients Enrolled for Corneas
Massachusetts Eye and Ear InfirmaryOTHER
106 Previous Clinical Trials
12,903 Total Patients Enrolled
1 Trials studying Corneas
90 Patients Enrolled for Corneas
Seok-Hyun Yun, PhDPrincipal InvestigatorMassachusetts General Hospital
2 Previous Clinical Trials
121 Total Patients Enrolled
1 Trials studying Corneas
90 Patients Enrolled for Corneas

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible for me to enroll in this experiment?

"This medical study is seeking up to 90 individuals with healthy eyes and aged between 18-79. Qualified candidates may be given the opportunity to participate in this trial."

Answered by AI

What is the scope of individuals taking part in this research project?

"Correct. According to the information on clinicaltrials.gov, this medical investigation is actively taking in participants. It was initially posted on August 1st 2019 and its most recent update occurred on July 30th 2022; it aims to enlist 90 individuals from a single location."

Answered by AI

Are there still opportunities for participants to join this research endeavor?

"As indicated on clinicaltrials.gov, the search for participants in this medical trial is ongoing and has been since its inception on August 1st 2019 with a recent update made July 30th 2022."

Answered by AI

Does the research project accept participants who are younger than 35 years old?

"Those that wish to take part in this research must be between 18 and 79 years of age. For those under the legal age of adulthood, 3 medical trials are available; for seniors over 65, 15 different studies have been made accessible."

Answered by AI
Recent research and studies
OphthalmologyJournal
Sensitivity and Specificity of Posterior Corneal Elevation Measured by Pentacam in Discriminating Keratoconus/subclinical Keratoconus
de Sanctis, Ugo, Carlotta Loiacono, Lorenzo Richiardi, Davide Turco, Bernardo Mutani, and Federico M. Grignolo. 2008. “Sensitivity and Specificity of Posterior Corneal Elevation Measured by Pentacam in Discriminating Keratoconus/subclinical Keratoconus”. Ophthalmology. Elsevier BV. doi:10.1016/j.ophtha.2008.02.020.
OphthalmologyJournal
Longitudinal Study of the Normal Eyes in Unilateral Keratoconus Patients
Li, X. 2004. “Longitudinal Study of the Normal Eyes in Unilateral Keratoconus Patients”. Ophthalmology. Elsevier BV. doi:10.1016/j.ophtha.2003.06.020.
American Journal of OphthalmologyJournal
Riboflavin/ultraviolet-a–induced Collagen Crosslinking for the Treatment of Keratoconus
Wollensak, Gregor, Eberhard Spoerl, and Theo Seiler. 2003. “Riboflavin/ultraviolet-a–induced Collagen Crosslinking for the Treatment of Keratoconus”. American Journal of Ophthalmology. Elsevier BV. doi:10.1016/s0002-9394(02)02220-1.
clinicaltrials.govStudy
Age-dependency of Cornea Biomechanics Using OCT Vibrography
Seok Hyun Yun 2019. "Age-dependency of Cornea Biomechanics Using OCT Vibrography". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03230981.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top